Jason Breaux
Analyst · Raymond James
Thanks, Dan. Hello, everyone, and thank you for joining us. We appreciate your continued interest in CCAP. For our call today, I’ll provide a few highlights from this quarter’s results, review our investing activity, provide some thoughts on our current portfolio and positioning and then turn it over to Gerhard to review our quarterly financial results in more detail before we open the call to Q&A. So let’s begin. Please turn to Slide 6, where you’ll see a summary of our results. We reported strong second quarter financial results with adjusted net investment income of $0.53 per share. Similar to the prior quarter, we accrued a cap gains incentive fee expense related to changes in net realized and unrealized gains and losses. This non-cash expense, which was not paid and is not payable, was approximately $0.14 per share for the quarter. Our Q2 net investment income per share, inclusive of the accrued capital gains based incentive fee expense, was $0.39, respectively. As a reminder, the capital gains fee is only payable at the end of each fiscal year based on our investment advisory agreement. If we were to hypothetically end the year as of June 30, the $0.19 per share of cumulative accrued capital gains incentive fees that we had at quarter end would not be paid or payable since the gains must be realized in order for us to be eligible to receive the fee. Turning back to our results, our net asset value per share increased for the fifth consecutive quarter, up approximately 3.7% in Q2 to $20.98, the highest value since CCAP’s inception. Gerard will walk through the key drivers in more detail, but the increase this quarter was primarily driven by a net change in unrealized appreciation, specific to certain portfolio companies where we hold equity. Please turn to Slide 4, which highlights our historical NAV trajectory and cumulative dividends since inception. Focusing on the right-hand side of the page, our business has performed well through the pandemic. From a total economic returns perspective, which is change in NAV plus dividends paid, we’ve generated over 20% since the year ended 2019, just prior to the onset of COVID-19. This was driven by growth in our net asset value per share, up 7.6% in that time frame, and the payment of our quarterly base dividends, which cumulatively represent another 12.6%. Overall, we’re pleased with this outcome and with our total investment portfolio carried at 105% of cost as at quarter end versus 103% last quarter, we remain comforted by the quality of our portfolio and its performance, particularly given the volatility we’ve all experienced since March of last year. Let’s now shift gears and turn to Slides 13 and 14 of the presentation, which provide a snapshot of the current portfolio. We ended the quarter with about $1.1 billion of investments at fair value across 130 portfolio companies with an average investment size of less than 1% of the total portfolio. Our investment portfolio continues to consist primarily of senior secured first lien and unitranche first lien loans. We are well diversified across 20 industries and lend primarily to private equity-backed companies. 99% of our debt portfolio was in sponsor-backed companies as of quarter end, consistent with prior quarters, and 80% of the portfolio at fair value was first lien, in line with Q1. For the second quarter, 116 out of our 117 debt investment portfolio companies, representing over 99% of total debt investments at fair value, made full scheduled principal and interest payments, and PIK interest represented just under 4% of total investment income in Q2. 90% of our debt investment portfolio today is marked above $0.95 on the dollar with an average mark of approximately 98%. Two more positive credit trends are outlined on Slide 17, continued strong performance ratings and non-accrual levels. Our weighted average portfolio grade of 2.1 was unchanged as compared to last quarter. And the percentage of risk rated 1 and 2 investments, the highest ratings our portfolio companies can receive, increased modestly to 88.1% of the portfolio at fair value as compared to 87.6% last quarter. As of quarter end, we had investments in two portfolio companies on non-accrual status, representing 1.6% and 1.2% of our total debt investments at cost and fair value, respectively. Moving to our investment activity, please turn to Slide 15. In terms of the broader market backdrop, while we have seen an increase in competition, which has resulted in some pressure on spreads, we continue to see growth in demand for large direct lending solutions. This is positive from our lens, given we continue to benefit from Crescent’s long-standing reputation as a reliable partner and our ability to offer surety of capital and scaled financing solutions to the sponsor community. Sponsors and portfolio company management teams alike are, in our view, exhibiting a strong preference for flexibility of capital and a long-term partnership approach with firms like ours, particularly given our focus on first lien and unitranche solutions. CCAP’s gross deployment in the second quarter totaled $121 million, nearly all of which or approximately 97% was in senior secured first lien or unitranche first lien investments. All told, we closed on 11 new investments and 13 follow-ons, totaling 76 and $32 million, respectively, with the remaining $13 million coming from revolver and delayed draw term loan activity during the quarter. All 11 of the new investments were private equity-backed loans at 475 to 650-basis point spreads, each with the LIBOR floor and OIDs between 1% and 3%. In addition, loan-to-value levels remain attractive, averaging approximately 39% for these transactions. The $121 million in gross deployment compares to $109.6 million in aggregate exits, sales and repayments in the quarter. It’s also worth highlighting that CCAP’s total commitments for the 11 aforementioned new deals represented only 17% of the over $500 million total check size committed to these new deals across Crescent, highlighting the breadth of our platform. Activity in the third quarter has been strong. For the month of July, we closed on 6 new investments totaling $58 million. The new investments are each private equity-backed, first lien or unitranche loans, with spreads, LIBOR floors and other characteristics comparable to the aforementioned Q2 investments. Two more updates before I turn it over to Gerhard. First, Sun Life entered its previously announced stock purchase program in May with CCAP share purchases commencing on June 29. The program will make open market purchases of shares of our common stock in an aggregate amount of up to $10 million and will be in effect for approximately 12 months unless extended or until the aggregate approved purchase amount has been expended. And finally, our Board has declared a $0.41 per share quarterly cash dividend for the third quarter of 2021, payable on October 15 to stockholders of record as of the close of business on September 30. With that, I’ll now turn it over to Gerhard to cover additional details on the quarter. Gerhard?